Clinical Trial

Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome

Study acronym: ParvoPre
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 13, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to define the rate of intrauterine parvovirus B19 infection and fetal/newborn complications after parvovirus B19 infection of pregnant women. Secondary objectives are risk factors, pregnancy outcomes, long-term sequelae and efficacy of the management interventions.
Trial Details
NCT Number NCT07338279
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Collaborators: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, ASST Fatebenefratelli Sacco, Fondazione IRCCS San Gerardo dei Tintori, Asst Degli Spedali Civili Di Brescia
Conditions Parvovirus B19 Infection, Pregnancy
Enrollment 150 participants
Start Date 2025-03-06
Primary Completion 2026-03 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-13